This is a rare bone disorder where fibrous tissue replaces normal bone in just one bone. It can cause pain or make the bone weaker. It usually doesn't cause major problems, but it can sometimes lead to fractures.
Every report comes from a Lived member, sent anonymously.
Have you had Fracture fixation surgery for Monostotic Fibrous Dysplasia?
Monostotic fibrous dysplasia is a noncancerous bone condition in which part of a single bone forms with soft, fibrous tissue and immature bone instead of normal, solid bone. The affected area, called a lesion, is weaker than the bone around it. It can expand, ache, bend or break, but many lesions cause no symptoms at all and are found by chance on an X-ray taken for something else. It is the most common form of fibrous dysplasia, making up roughly 70 to 80 percent of cases, and it is usually discovered between the ages of 10 and 30. The bones most often involved are the ribs, the upper part of the thighbone (femur) and the bones of the skull and face, particularly the upper jaw. "Monostotic" means one bone. When several bones are involved the condition is called polyostotic fibrous dysplasia, and when bone lesions occur together with certain skin patches or hormone problems, they are part of McCune-Albright syndrome. The single-bone form sits at the mildest end of this range.
Fibrous dysplasia is caused by a change (mutation) in a gene called GNAS that happens by chance in one cell during early development, before birth. Cells descended from that cell carry the change, and in bone they produce the abnormal fibrous tissue. How early the change happens, and how far those cells spread, helps explain why some people have a single small lesion while others have many bones involved. Because the change arises after conception rather than being carried in a parent's egg or sperm, fibrous dysplasia is not an inherited condition and is not expected to run in families. No known exposure, food, injury or behavior causes it, and it affects males and females equally.
Fibrous dysplasia often has a characteristic look on an X-ray: a well-defined area of bone with a hazy, "ground glass" appearance, sometimes with the bone widened or bowed. A CT (computed tomography) scan gives more detail in complex areas such as the skull, face and pelvis, and MRI (magnetic resonance imaging) can help separate fibrous dysplasia from a fluid-filled bone cyst. A bone scan, in which a small amount of radioactive tracer highlights active bone throughout the skeleton, may be used to check whether other bones are involved, since that decides whether the condition is truly limited to one bone. A single lesion with no other features can resemble several other problems, including simple bone cysts, other benign bone tumors and, rarely, cancer. For that reason a biopsy, in which a small sample of the lesion is removed and examined under a microscope, is often needed to confirm the diagnosis. When the result is still unclear, particularly for a single lesion in the skull, the sample can be tested for the GNAS change. Blood tests such as alkaline phosphatase, an enzyme that rises when bone is being actively built, may be checked, but they are not specific to fibrous dysplasia. A thorough assessment also looks for signs that would point to McCune-Albright syndrome instead, such as light-brown birthmarks with jagged edges or signs of hormone overactivity like unusually early puberty, because those change the follow-up plan.
Many single lesions need no treatment. When a lesion causes no pain and sits where it is unlikely to break, the usual approach is observation: periodic checkups, with imaging guided by symptoms rather than repeated on a fixed schedule in adults. Treatment cannot undo the gene change, so its goals are to relieve pain, prevent or repair fractures, correct deformity and protect nearby structures such as nerves and the eyes. For bone pain, the main medicine option is an intravenous bisphosphonate, a type of drug that slows the cells that break down bone. Pamidronate or zoledronic acid given by infusion relieves pain for some people; a few doses are given to see whether they help, and they are stopped if pain does not improve. Bisphosphonate pills have not helped fibrous dysplasia pain in a controlled trial and are not recommended for it, and it is still unclear whether any bisphosphonate shrinks lesions or prevents fractures. A dental check is advised before starting, to lower the risk of osteonecrosis of the jaw, a complication in which part of the jawbone breaks down and fails to heal. Denosumab, an injected antibody that strongly suppresses bone breakdown, has reduced pain and lesion activity in small studies, but stopping it has caused sharp rises in blood calcium in some people, so experts reserve it for specialist centers and clinical studies. Surgery is considered for a fracture, a lesion at high risk of breaking (such as one in the upper thighbone), a worsening deformity, or a lesion pressing on a nerve, the eye or the airway. In leg bones, surgeons usually stabilize the bone with a metal rod or plate, because simply scraping out the lesion and packing it with bone graft tends not to last. Skull and face lesions are usually watched unless they affect vision, hearing, breathing or appearance, and any operation there is best planned by an experienced craniofacial team. Operations done mainly for pain do not always relieve it, so the decision also weighs fracture risk and function.
For most people, monostotic fibrous dysplasia is a lifelong but manageable finding rather than a progressive illness. A single lesion may grow somewhat while the skeleton is still growing, but it usually becomes inactive once growth ends, and new lesions in other bones do not appear later in life. The lesion itself does not disappear, though, and that spot of bone stays weaker than normal. Daily effects depend on where the lesion is. A rib lesion often goes unnoticed for life. A lesion in the thighbone or shinbone may ache with activity and ease with rest, and it carries some risk of breaking; fractures through fibrous dysplasia usually heal but can happen again in the same place. A lesion in the skull or jaw may show up as a slowly enlarging bump or facial asymmetry, and routine dental and orthodontic care can generally go ahead. Children and teenagers are usually followed more closely while they grow, while adults with a stable, painless lesion often need imaging only when symptoms change. The lesion turning cancerous is very rare, happening in under 1 percent of people with fibrous dysplasia, and it is less likely with a single lesion than with the more extensive forms.
See a doctor about a bone lesion found by chance on an X-ray, or about ongoing bone pain, a firm bump on a bone, a limp or a bone that looks bent, so the lesion can be identified and its risk of breaking judged. Ideally the assessment includes a specialist familiar with fibrous dysplasia. If you already know you have a lesion, contact your care team promptly about pain that is new or steadily worsening, pain that wakes you at night or does not ease with rest, pain in a leg bone when you put weight on it, or a lesion that suddenly swells or grows. These can signal an impending fracture, bleeding into a cyst within the lesion or, very rarely, cancer. With a skull or face lesion, any change in vision, double vision, a bulging eye or new hearing loss needs urgent assessment. Sudden severe pain in the affected bone after a fall or twist, especially with trouble moving the limb or bearing weight, may mean a fracture and should be seen the same day.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Monostotic Fibrous Dysplasia is like, what's helped you, or ask the community a question.